Urea Breath Tests Market: A detailed look at the industry.

The urea breath test can be used to identify Helicobacter Pylori (H.pylori), which is a bacterium that can infect the stomach. It is also the leading cause of stomach and duodenal ulcers, the first part of the small intestine. H. pylori produces urease, an enzyme that converts urea to carbon dioxide and ammonia. The test involves swallowing a urea tablet and measuring the amount of carbon dioxide exhaled. This indicates that H. pylori are present in the stomach.

Request a sample to get more information on the Urea Breath Tests market (Use Corporate email ID to Get Higher Priority): https://market.us/report/urea-breath-test-market/request-sample/

Detail Segmentation
Global urea breath market segments are based on – Test Type and Product Type, Method, End User, and Region. Below is a detailed segmental description.

Based on the Test Type:
• Point-of Care Tests (POCT).
• Labor-based Testing
• Based on Product Type
• Breath Analyzer
• UBT-kits

Based on the Method:
• Mass Spectrometer
• Infrared Spectrometer
• Laser-assisted Rationalizer

Based on End-User
• Hospitals
• Clinics
• Diagnostic Centers
• Standalone Labs
• Private Lab Networks

Based on the Region
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

Market Dynamics –

Global Urea Breath Test Market Drivers:
This market is expected to grow over the forecast period due to increased product approvals from regulatory bodies. In February 2020, Gulf Coast Scientific Inc., a medical equipment company, announced that the Pylo Plus UBT System was approved by the US Food & Drug Administration. The Pylo Plus UBT System, a 13C urine breath test for Helicobacter Pylori (H. Pylori) infection detection, is available. This market will continue to grow due to increased attention on market tactics like acquisitions and collaborations with key competitors. In October 2016, MAYOLY SPINDLER (a top pharmaceutical company) purchased Kibion from Sweden, a leading manufacturer, and supplier of urea breath testing methods. This acquisition allowed MAYOLY to expand its product range, which included Diabact UBT and Kibion’s C-13 Urea Breath Test. It also includes breath sample analyzers like Heliprobe or Kibion Dynamic. Kibion is also a prominent player in Hpylori detection markets in countries like the UAE, Iran, and Germany. These factors will be a major contributor to the growth of this market over the coming years.

Competitive Landscape –
Mayoli Spindler (Kibion AB), Otsuka Pharmaceutical Co. Ltd., Sercon Group, Meridian Bioscience, Paladin Labs Inc., Beijing Richen- Force Science & Technology Co. Ltd., Fisher Analysen Methode GmbH (FAN), Avanos Medical Inc., Beijing Binal Health Bio-Sci & Tech Co. Ltd, Kizlon Medical, and Gulf Coast Scientific Inc., among others. are some of the key players in this market. To maintain their competitive edge, these key industry players are now focusing upon mergers, partnerships and acquisitions, product development, and collaboration strategies.

The Key Developments
The year 2019
Otsuka Pharmaceutical Co. Ltd. in Japan introduced the POConePlus Infrared Spectrophotometer to detect H. pylori. The gadget measures variations in carbon dioxide isotope ratios in exhaled air to determine if H. Pylori is present.